^
CANCER:

Ampulla of Vater Carcinoma

KRAS G12C
Ampulla of Vater Carcinoma
sotorasib
Sensitive: C1 - Off-label
MUC2 negative
Ampulla of Vater Carcinoma
gemcitabine
Resistant: C3 – Early Trials
KRT7 expression
Ampulla of Vater Carcinoma
gemcitabine
Resistant: C3 – Early Trials
KRT7 expression
Ampulla of Vater Carcinoma
cisplatin + gemcitabine + albumin-bound paclitaxel
Sensitive: C3 – Early Trials
KRT7 expression + MUC1 expression
Ampulla of Vater Carcinoma
gemcitabine + albumin-bound paclitaxel
Sensitive: C3 – Early Trials
HER-2 mutation + CDK6 mutation
Ampulla of Vater Carcinoma
palbociclib + pertuzumab + ribociclib + abemaciclib + trastuzumab/hyaluronidase-oysk
Sensitive: C3 – Early Trials
BRAF D594G
Ampulla of Vater Carcinoma
encorafenib + binimetinib
Sensitive: C3 – Early Trials
PIK3CA mutation
Ampulla of Vater Carcinoma
everolimus
Sensitive: C4 – Case Studies
NRAS mutation + BRAF mutation
Ampulla of Vater Carcinoma
MEK inhibitor
Sensitive: C4 – Case Studies
HER-2 G660D + HER-2 S310F
Ampulla of Vater Carcinoma
afatinib
Sensitive: C4 – Case Studies